CRDL
Cardiol Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.88
+0.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 13.26x
- Price / sales
- —
- Price / cash flow
- -13.24x
Enterprise value
- Enterprise value
- $209.3M
- EV / sales
- —
- EV / EBITDA
- -7.94x
- EV / EBIT
- -7.46x
- Market cap
- $227.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026